Houlihan Lokey Advises ClareMedica

Houlihan Lokey is pleased to announce that ClareMedica Health Partners (ClareMedica), a portfolio company of BPOC, has been acquired by Revelstoke Capital Partners (Revelstoke). The transaction closed on February 11, 2022.

Headquartered in Miami Lakes, Florida, ClareMedica Health Partners (ClareMedica) provides and coordinates comprehensive healthcare services for Medicare Advantage members and other customers through a network of employed and affiliated physicians. ClareMedica delivers high-quality, community-based care through eight wholly owned practices and over 25 affiliated practices. The company’s culture is founded on a patient-centric model designed to improve health outcomes and patient experience while lowering medical costs across key stakeholders.

Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies in the healthcare services and healthcare technology sectors. Revelstoke partners with entrepreneurs and management teams to execute on a disciplined organic and acquisition growth strategy as it strives to build exceptional companies. Revelstoke is based in Denver, Colorado, and has approximately $4.3 billion of assets under management. Since the firm’s inception in 2013, Revelstoke has completed 142 acquisitions, which includes 25 platform companies and 117 add-on acquisitions.

Founded in 1996, BPOC is a Chicago-based private equity firm that invests exclusively in healthcare companies and is one of the nation’s most experienced investors in the industry, having raised five funds with total capital commitments of nearly $1.8 billion. BPOC has invested in numerous provider, manufacturing, outsourcing, distribution, and information technology companies through growth equity, management buyouts, and leveraged recapitalizations.

This transaction further strengthens and highlights Houlihan Lokey’s continued leadership position in value-based care and Medicare Advantage. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2021, the group closed more than 60 transactions and was ranked the No. 1 M&A advisor for global healthcare transactions under $1 billion by Refinitiv*.

Houlihan Lokey served as the exclusive financial advisor to ClareMedica and assisted in initiating, structuring, and negotiating the transaction on its behalf.

*Excludes accounting firms and brokers.